SLC6A14 and cystic fibrosis: An increase in SLC6A14-mediated arginine uptake would be expected to overcome decreased arginine bioavailability in CF tissues, and enhance NO and cGMP-mediated ‘priming’ of F508del-CFTR channel activity at the cell surface.